Contemporary outcome measures in acute stroke research: Choice of primary outcome measure

Stroke

Volumn 43, Issue 4, 2012, Pages 1163-1170

  Lees, Kennedy R ^a   Bath, Philip M W ^b   Schellinger, Peter D ^b   Kerr, Daniel M ^b   Fulton, Rachael ^b   Hacke, Werner ^b   Matchar, David ^b   Sehra, Ruchir ^b   Toni, Danilo ^b  

^a UNIVERSITY OF GLASGOW   (United Kingdom)

^b NONE

Author keywords

acute stroke; interpretation; outcomes; randomized controlled trials

Indexed keywords

ACUTE STROKE; BARTHEL INDEX; CLINICAL PRACTICE; CORRELATION COEFFICIENT; EUROQOL 5D SCALE; GLASGOW OUTCOME SCALE; HUMAN; INTERRATER RELIABILITY; INTRARATER RELIABILITY; MOTOR PERFORMANCE; NATIONAL INSTITUTES OF HEALTH STROKE SCALE; OUTCOME ASSESSMENT; PRIORITY JOURNAL; QUALITY OF LIFE; RANKIN SCALE; RATING SCALE; REVIEW; SCANDINAVIAN RATING SCALE; STROKE; VALIDITY;

HUMANS; STROKE;

EID: 84859433324     PISSN: 00392499     EISSN: 15244628     Source Type: Journal    
DOI: 10.1161/STROKEAHA.111.641423     Document Type: Review

References (61)

1. Quinn TJ, Dawson J, Walters MR, Lees KR. Functional outcome measures in contemporary stroke trials. Int J Stroke. 2009;4:200-205.
2. Bath PMW, Lees KR, Schellinger PD, Altman H, Bland M, Hogg C, et al. Statistical analysis of the primary outcome in a acute stroke trials. Stroke. 2012;43:1171-1178
3. Kasner SE. Clinical interpretation and use of stroke scales. Lancet Neurol. 2006;5:603-612 (Pubitemid 43867434)
4. Ali M, Bath PM, Curram J, Davis SM, Diener HC, Donnan GA, et al. The Virtual International Stroke Trials Archive. Stroke. 2007;38:1905-1910 (Pubitemid 46847267)
5. Stroke CDE Working Group. Stroke CDE Standards. Available at: http://www.commondataelements.ninds.nih.gov/Stroke.aspx 2010. Accessed February 28, 2011
6. The European Agency for Evaluation of Medicinal Products-Evaluation of Medicines for Human Use. Points to consider on clinical investigation of medicinal products for the treatment of acute stroke. Available at http://www.ema.europa.eu/docs/en-GB/document-library/Scientific-guideline/2009/ 09/WC500003342.pdf London 20 September 2001 CPMP/EWP/560/98. Accessed April, 21,2011.
7. US Food and Drug Administration. Guidance for Industry and FDA Staff-Pre-Clinical and Clinical Studies for Neurothrombectomy Devices. Available at: http://www.fda.gov/MedicalDevices/Device RegulationandGuidance/ GuidanceDocuments/ucm071403.htm June 18, 2007 Accessed April 21, 2011
8. Gray LJ, Ali M, Lyden PD, Bath PM. Virtual International Stroke Trials Archive Collaboration. Interconversion of the National Institutes of Health stroke scale and Scandinavian stroke scale in acute stroke. J Stroke Cerebrovasc Dis. 2009;18:466-468.
9. Schellinger PD, Bath PMW, Lees KR, Bornstein NM, Uriel E, Eisert W, Leys D for the European Stroke Organization Outcomes Working Group. Assessment of additional endpoints relevant to the benefit of patients after stroke: what, when where, in whom. International J Stroke. 2012; in press
10. Rankin J. Cerebral vascular accidents in patients over the age of 60. II. Prognosis. Scott Med J. 1957;2:200-215
11. Farrell B, Godwin J, Richards S, Warlow C. The United Kingdom transient ischaemic attack (UK-TIA) aspirin trial: final results. J Neurol Neurosurg Psychiatry. 1991;54:1044-1054
12. van Swieten JC, Koudstaal PJ, Visser MC, Schouten HJ, van Gijn J. Interobserver agreement for the assessment of handicap in stroke patients. Stroke. 1988;19:604-607
13. Lyden P, Brott T, Tilley B, Welch KM, Mascha EJ, Levine S, et al. Improved reliability of the NIH stroke scale using video training. NINDS TPA Stroke Study Group. Stroke. 1994;25:2220-2226 (Pubitemid 24338379)
14. Mahoney F, Barthel D. Functional evaluation: the Barthel Index. Md Med J. 1965;14:61-65
15. Granger CV, Dewis LS, Peters NC, Sherwood CC, Barrett JE. Stroke rehabilitation: analysis of repeated Barthel index measures. Arch Phys Med Rehabil. 1979;60:14-17 (Pubitemid 9101111)
16. Teasdale GM, Pettigrew LE, Wilson JT, Murray G, Jennett B. Analyzing outcome of treatment of severe head injury: A review and update on advancing the use of the Glasgow Outcome Scale. J Neurotrauma. 1998; 15:587-597 (Pubitemid 28413052)
17. Wilson JT, Pettigrew LE, Teasdale GM. Structured interviews for the Glasgow Outcome Scale and the extended Glasgow Outcome Scale: guidelines for their use. J Neurotrauma. 1998;15:573-585
18. The EuroQol Group. EuroQol-a new facility for the measurement of health-related quality of life. Health Policy. 1990;16:199-208
19. Xie J, Wu EQ, Zheng ZJ, Croft JB, Greenlund KJ, Mensah GA, et al. Impact of stroke on health-related quality of life in the noninstitutionalized population in the United States. Stroke. 2006;37:2567-2572 (Pubitemid 44454681)
20. Lu M, Tilley BC, NINDS t-PA Stroke Trial Study Group. Use of odds ratio or relative risk to measure a treatment effect in clinical trials with multiple correlated binary outcomes: data from the NINDS t-PA stroke trial. Statist Med. 2001;20:1891-1901 (Pubitemid 32605719)
21. Tilley BC, Marler J, Geller NL, Lu M, Legler J, Brott T, et al. Use of a global test for multiple outcomes in stroke trials with application to the National Institute of Neurological Disorders and Stroke t-PA Stroke Trial. Stroke. 1996;27:2136-2142 (Pubitemid 26372593)
22. Vahedi K, Hofmeijer J, Juettler E, Vicaut E, George B, Algra A, et al. Early decompressive surgery in malignant infarction of the middle cerebral artery: A pooled analysis of three randomised controlled trials. Lancet Neurol. 2007;6:215-222 (Pubitemid 46237760)
23. Hofmeijer J, Kappelle LJ, Algra A, Amelink GJ, van Gijn J, van der Worp HB, et al. Surgical decompression for space-occupying cerebral infarction (the Hemicraniectomy After Middle Cerebral Artery infarction with Lifethreatening Edema Trial [HAMLET]): A multicentre, open, randomised trial. Lancet Neurol. 2009;8:326-333
24. Saver JL, Johnston KC, Homer D, Wityk R, Koroshetz W, Truskowski LL, et al. Infarct volume as a surrogate or auxiliary outcome measure in ischemic stroke clinical trials. The RANTTAS Investigators. Stroke. 1999;30:293-298 (Pubitemid 29071792)
25. Engelter ST, Provenzale JM, Petrella JR, DeLong DM, Alberts MJ. Infarct volume on apparent diffusion coefficient maps correlates with length of stay and outcome after middle cerebral artery stroke. Cerebrovascular Diseases. 2003;15:188-191 (Pubitemid 36351204)
26. Dawson J, Lees JS, Chang TP, Walters MR, Ali M, Davis SM, et al. Association between disability measures and healthcare costs after initial treatment for acute stroke. Stroke. 2007;38:1893-1898 (Pubitemid 46847265)
27. Lyden PD, Lu M, Levine SR, Brott TG, Broderick J, NINDS rtPA Stroke Study Group. A modified National Institutes of Health Stroke Scale for use in stroke clinical trials: preliminary reliability and validity. Stroke. 2001;32:131-1317
28. Granger CV, Hamilton BB, Gresham GE. The stroke rehabilitation outcome study-Part I: General description. Arch Phys Med Rehabil. 1988;69:506-509
29. Goldstein LB, Bertels C, Davis JN. Interrater reliability of the NIH stroke scale. Arch Neurol. 1989;46:660-662 (Pubitemid 19150945)
30. Shah S, Vanclay F, Cooper B. Improving the sensitivity of the Barthel Index for stroke rehabilitation. J Clin Epidemiol. 1989;42:703-709 (Pubitemid 19213114)
31. Saver JL, Filip B, Hamilton S, Yanes A, Craig S, Cho M, et al. Improving the reliability of stroke disability grading in clinical trials and clinical practice: the Rankin Focused Assessment (RFA). Stroke. 2010;41: 992-995
32. Bruno A, Shah N, Lin C, Close B, Hess DC, Davis K, et al. Improving modified Rankin Scale assessment with a simplified questionnaire. Stroke. 2010;41:1048-1050
33. Wilson JT, Hareendran A, Grant M, Baird T, Schulz UG, Muir KW, et al. Improving the assessment of outcomes in stroke: use of a structured interview to assign grades on the modified Rankin Scale. Stroke. 2002; 33:2243-2246 (Pubitemid 35014637)
34. Quinn TJ, Lees KR, Hardemark HG, Dawson J, Walters MR. Initial experience of a digital training resource for modified Rankin scale assessment in clinical trials. Stroke. 2007;38:2257-2261 (Pubitemid 47457565)
35. Wahlgren N, Ahmed N, Dávalos A, Ford GA, Grond M, Hacke W, et al. Thrombolysis with alteplase for acute ischaemic stroke in the Safe Implementation of Thrombolysis in Stroke-Monitoring Study (SITS-MOST): an observational study. Lancet. 2007;369:275-282 (Pubitemid 46138121)
36. Weimar C, Kurth T, Kraywinkel K, Wagner M, Busse O, Haberl RL, et al. Assessment of functioning and disability after ischemic stroke. Stroke. 2002;33:2053-2059 (Pubitemid 34840067)
37. Shinar D, Gross CR, Bronstein KS, Licata-Gehr EE, Eden DT, Cabrara AR, et al. Reliability of the activities of daily living scale and its use in the telephone interview. Arch Phys Med Rehabil. 1987;68:723-728 (Pubitemid 17149890)
38. Quinn TJ, Dawson J, Walters MR, Lees KR. Reliability of the modified Rankin Scale: A systematic review. Stroke. 2009;40:3393-3395
39. Spearman, Charles C. Correlation calculated from faulty data. Br J Psychol. 1910;3:271-295
40. Brown W. Some experimental results in the correlation of mental abilities. Br J Psychol. 1910;3:296-322
41. McArthur K, Lees KR. Central Adjudication of Modified Rankin Scale Disability Assessments in Acute Stroke Trials. Report to Chief Scientist Office on grant CZB/4/595. January 14, 2011
42. Quinn TJ, Dawson J, Johnson PCD, McArthur K, Walters MR, Weir CJ, et al. Beneficial effect of improving modified Rankin Scale reliability on sample size for stroke trials. Proceedings of European Stroke Conference in Barcelona. Cerebrovasc Dis. 2010;29(Suppl 2):18
43. McArthur K, Xing H, Quinn TJ, Dawson J, Walters MR, Sun Wei, et al. Reliability and validity of a translated modified Rankin Scale assessment-a pilot study in Mandarin and English. Stroke. 2011;42:e247
44. Pezzella FR, Picconi O, De Luca A, Lyden PD, Fiorelli M. Development of the Italian version of the National Institutes of Health Stroke Scale: It-NIHSS. Stroke. 2009;40:2557-2559
45. Hong KS, Saver JL. Quantifying the value of stroke disability outcomes: WHO global burden of disease project disability weights for each level of the modified Rankin Scale. Stroke. 2009;40:3828-3833
46. Quinn TJ, Dawson J, Lees JS, Chang TP, Walters MR, Lees KR, et al. Time spent at home poststroke "home-time" a meaningful and robust outcome measure for stroke trials. Stroke. 2008;39:231-233
47. Samsa GP, Matchar DB. Have randomized controlled trials of neuroprotective drugs been underpowered? An illustration of three statistical principles. Stroke. 2001;32:669-674
48. Mendelow AD, Gregson BA, Fernandes HM, Murray GD, Teasdale GM, Hope DT, et al. Early surgery versus initial conservative treatment in patients with spontaneous supratentorial intracerebral haematomas in the International Surgical Trial in Intracerebral Haemorrhage (STICH): A randomised trial. Lancet. 2005;365:387-397 (Pubitemid 40179225)
49. Quinn TJ, Dawson J, Walters MR, Lees KR. Variability in modified Rankin scoring across a large cohort of international observers. Stroke. 2008;39:2975-2979
50. Wilson JT, Hareendran A, Hendry A, Potter J, Bone I, Muir KW. Reliability of the modified Rankin Scale across multiple raters: benefits of a structured interview. Stroke. 2005;36:777-781
51. Newcommon NJ, Green TL, Haley E, Cooke T, Hill MD, Wilson MD, et al. Improving the assessment of outcomes in stroke: use of a structured interview to assign grades on the modified Rankin scale. Stroke. 2003; 34:377-378 (Pubitemid 36206332)
52. Quinn TJ, Dawson J, Walters MR, Lees KR. Exploring the reliability of the modified Rankin scale. Stroke. 2009;40:762-766
53. Quinn TJ, Dawson J, Walters MR, Lees KR. Reliability of the modified Rankin Scale. Stroke. 2007;38:e144
54. Quinn TJ, Dawson J, Walters MR, Lees KR. Predicting variability in modified Rankin Scale assessment. Cerebrovascular Dis. 2009;27(Suppl 6):I-121
55. Uyttenboogaart M, Stewart RE, Vroomen PC, De Keyser J, Luijckx GJ. Optimizing cutoff scores for the Barthel Index and the modified Rankin scale for defining outcome in acute stroke trials. Stroke. 2005;36: 1984-1987 (Pubitemid 41266538)
56. Saver JL, Gornbein J. Treatment effects for which shift or binary analyses are advantageous in acute stroke trials. Neurology. 2009;72:1310
57. OAST Collaboration. Calculation of Numbers-Needed-to-Treat (NNT) in parallel group trials assessing ordinal outcomes: Case examples from acute stroke and stroke prevention. Int J Stroke. 2011;6:472-479
58. Spieler JF, Lanoe JL, Amarenco P. Costs of stroke care according to handicap levels and stroke subtypes. Cerebrovasc Dis. 2004;17:134-142 (Pubitemid 38529189)
59. Samsa GP, Matchar DB, Goldstein L, Bonito A, Duncan PW, Lipscomb J, et al. Utilities for major stroke: Results from a survey preferences among persons at increased risk for stroke. Am Heart J. 1998;136: 703-713 (Pubitemid 28483514)
60. Mishra NK, Shuaib A, Lyden P, Diener HC, Grotta J, Davis S, et al. Home time is extended in ischemic stroke patients who receive thrombolytic therapy: A validation study of home time as an outcome measure. Stroke. 2011;42:1046-1050
61. Rosenberg G, Bornstein N, Diener HC, Gorelick PB, Shuaib A, Lees K, et al. The Membrane-Activated Chelator Stroke Intervention (MACSI) Trial of DP-b99 in acute ischemic stroke: A randomized, double-blind, placebo-controlled, multi-national pivotal phase III study. Int J Stroke. 2011;6:362-367.